← Back to news

Markets

Grindr (GRND): Firm Reaffirms 2025 Revenue Growth Outlook

Y

Alkami Technology (ALKT): Jana Lauds Organic Top Line Growth

Y

Intel stock soared in 2025. But the chipmaker still has a long road ahead.

Y

Chevron Could Raise Its Dividend Next Month - CVX Stock Looks Too Cheap

Y

25 Reasons to Buy Joby Aviation Stock for 2026

Y

‘DeFi is dead’: Maple Finance’s CEO says onchain markets will swallow Wall Street

Y

The Stock Market’s Wild 2025 Roller-Coaster Ride in Six Charts

Y

Upstart Holdings (UPST): Firm Announces New Castlelake Deal

Y

Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch

Y

Clearwater Analytics Holdings (CWAN): Activist Investor Wants Share Price Boost

Y

Wingstop (WING): RBC Highlights Growth, Long US Runway

Y

ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance

Y

Dutch Bros (BROS): KeyBanc Highlights Compelling Growth Story

Y

Why Warren Buffett Just Sold 15% of His Apple Stake and Is Putting Money Here Instead

Y

VOO vs. MGK: Is S&P 500 Diversification or Mega-Cap Growth the Better Buy for Investors?

Y

The Stock Market Is Doing Something It's Only Done Twice Since 1871 -- Should You Be Worried for 2026?

Y

Jeff Bezos warned Americans not to buy a new 'refrigerator, or whatever.’ Fearmongering, or good advice for 2026?

Y

Here's your big free reminder on AI stocks for 2026

Y

Prediction: This Data Center REIT Could Double as AI Demand Soars

Y

The Secret to Finding the Next Broadcom Is Hiding in Plain Sight

Y

How Much Should You Have Saved To Retire at 65?

Y

SPGM vs. VT: Which Global ETF Is the Better Buy for Investors?

Y

Half of US Homes Have Lost Value This Year: Is the Market Cooling or Collapsing?

Y

Top Beaten-Down Data Center Infrastructure Stocks

S

Ellison’s hardball Warner Bros. tactics gave Netflix an opening

Y

Advisors Target Diversification in 2026 Strategies as Mag 7 Risk Rises

Y

Amazon Stock in 2026: Key Catalysts and What Investors Should Watch

Y

Private Equity must Invest 'Dry Powder' or Risk an Investor Exodus

Y

Which Small-Cap ETF Is Better: Vanguard's VB or iShares' ISCB?

Y

If You'd Invested $500 in Netflix 10 Years Ago, Here's How Much You'd Have Today

Y

After my divorce I ended up with a truck $7K underwater. Here are the best ways to manage your debt

Y

Stocks enter final stretch of 2025 just off record highs: What to watch this week

Y

Coty Completes Wella Divestment to Refocus on Fragrances

Y

Denison Mines Forms Joint Ventures With Skyharbour

Y

Jefferies Sees Structural Strength but Limited Upside for UWM Holdings Corporation (UWMC)

Y

Wall Street Keeps B2Gold Corp. (BTG) in Focus With Mixed Views

Y

BlackBerry Limited (BB) Outperforms Estimates but RBC Sticks With Sector Perform

Y

Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy?

Y

NIO Inc. (NIO) Holds Mixed Analyst Sentiment Despite Strong Median Upside Potential

Y

Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges

Y

Cosan S.A. (CSAN) Gets Negative Outlook from Fitch as Leverage Remains High

Y

Could This Bear-Market Buy Help You Become a Millionaire?

Y

Prediction: These 3 Stocks Will Join the $3 Trillion Club in 2026

Y

Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study

Y

Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program

Y

High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin

Y

Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data

Y

Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR)

Y

Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change

Y

Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress

Y